Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MMD's Cardizem (diltiazem)

Executive Summary

Marion Merrell Dow and its supplier of bulk diltiazem, Tanabe Seiyaku, file complaint with the International Trade Commission against at least eight foreign and U.S. firms MMD says have violated Tanabe's process patent for bulk diltiazem. Among the firms named in the complaint are Profarmaco Nobel, an Italian producer, and Mylan, its U.S. customer; Copley Pharmaceutical and its Finnish supplier Orion Corp. Fermion and ABIC Ltd., a subsidiary of Israeli firm Teva, which MMD says "supplies diltiazem to various companies." Rhone-Poulenc Rorer, which is already in litigation with MMD ("The Pink Sheet" Feb. 22, T&G-8) is also named in the ITC complaint.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS022224

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel